William Blair Investment Management LLC Sells 18,209 Shares of Merit Medical Systems, Inc. $MMSI

William Blair Investment Management LLC reduced its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 1.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,119,581 shares of the medical instruments supplier’s stock after selling 18,209 shares during the period. William Blair Investment Management LLC’s holdings in Merit Medical Systems were worth $96,541,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in MMSI. Kilter Group LLC bought a new stake in shares of Merit Medical Systems during the 2nd quarter worth about $25,000. Salomon & Ludwin LLC increased its holdings in shares of Merit Medical Systems by 140.8% during the 3rd quarter. Salomon & Ludwin LLC now owns 537 shares of the medical instruments supplier’s stock valued at $46,000 after acquiring an additional 314 shares during the last quarter. Harbor Investment Advisory LLC bought a new position in shares of Merit Medical Systems in the 2nd quarter valued at approximately $50,000. IFP Advisors Inc raised its stake in shares of Merit Medical Systems by 88.6% in the 3rd quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier’s stock valued at $60,000 after acquiring an additional 326 shares in the last quarter. Finally, Pinnacle Wealth Planning Services Inc. raised its stake in shares of Merit Medical Systems by 84.0% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 784 shares of the medical instruments supplier’s stock valued at $68,000 after acquiring an additional 358 shares in the last quarter. Institutional investors and hedge funds own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

NASDAQ MMSI opened at $86.63 on Monday. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.52 and a quick ratio of 3.05. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of 32.57, a P/E/G ratio of 2.11 and a beta of 0.56. The company’s fifty day moving average is $88.02 and its two-hundred day moving average is $77.40. Merit Medical Systems, Inc. has a 52-week low of $59.74 and a 52-week high of $94.85.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last announced its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.08. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The business had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. During the same quarter in the prior year, the business earned $0.92 earnings per share. The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. Equities research analysts forecast that Merit Medical Systems, Inc. will post 3.86 EPS for the current year.

Analyst Ratings Changes

MMSI has been the subject of several analyst reports. Wells Fargo & Company boosted their target price on Merit Medical Systems from $83.00 to $92.00 and gave the stock an “equal weight” rating in a report on Friday, October 30th. BTIG Research raised their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company a “buy” rating in a report on Friday, October 30th. Weiss Ratings raised Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, October 12th. Piper Sandler lifted their price target on Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Merit Medical Systems presently has an average rating of “Moderate Buy” and a consensus target price of $105.55.

Read Our Latest Research Report on Merit Medical Systems

About Merit Medical Systems

(Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

Featured Articles

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.